Kylonova (Xiamen) Biopharma co., LTD.
4 clinical trials · Sponsor
◉ Watch Kylonova (Xiamen) Biopharma co., LTD.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) (NCT07327840) | Kylonova (Xiamen) Biopharma co., LTD. | 2025-10-29 |
| Single-ascending Dose Study of Kylo-12 in Healthy Subjects (NCT06783881) | Kylonova (Xiamen) Biopharma co., LTD. | 2025-03-12 |
| Single-ascending Dose Study of Kylo-11 in Healthy Subjects (NCT06363851) | Kylonova (Xiamen) Biopharma co., LTD. | 2024-05-16 |
| Dose Escalation Study of Kylo-0603 in Healthy Subjects (NCT06365580) | Kylonova (Xiamen) Biopharma co., LTD. | 2023-05-23 |
Track Kylonova (Xiamen) Biopharma co., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.